Tus kws kho mob
QP26-22 Provider Directory Validation (PDV) Tool
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2022
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1811 - 1820 ntawm 3685
Tus kws kho mob
QP27-22 MHCP Pharmacy Benefit Exclusion for Fyarro
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2022
Tus kws kho mob
QP28-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit ( QL) Criteria: OpzeluraTM (ruxolitnib)
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2022
Tus kws kho mob
P20-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates — Effective June 6, 2022
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P21-22 Medical Drug Management Update – Infliximab Prior Authorization and Preferred Product Expansion to Include Unbranded Infliximab
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P22-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Tus kws kho mob
Opzelura™ (ruxolitinib) - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 01, 2024
Tus kws kho mob
Zeposia® (ozanimod) - Medicaid
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2025
Tus kws kho mob
P17-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P18-22 Non-Covered Procedure Codes for Minnesota Health Care Programs
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022